Lymphoid/JJ
cell/NN
resistance/NN
to/TO
glucocorticoids/NNS
in/IN
HIV/NN
infection/NN
./.

In/IN
humans/NNS
infected/VBN
with/IN
the/DT
HIV-1/NN
virus/NN
there/EX
may/MD
be/VB
a/DT
disproportionate/JJ
severity/NN
of/IN
signs/NNS
and/CC
symptoms/NNS
of/IN
illness/NN
compared/VBN
to/TO
the/DT
fraction/NN
of/IN
CD4+/JJ
infected/JJ
T-lymphoid/NN
cells/NNS
./.
=====
In/IN
part/NN
,/,
this/DT
may/MD
be/VB
due/JJ
to/TO
altered/JJ
intercellular/JJ
signalling/NN
systems/NNS
and/CC
intracellular/JJ
signal/NN
transduction/NN
./.
=====
Glucocorticoids/NNS
are/VBP
well/RB
known/JJ
for/IN
their/PRP$
effects/NNS
on/IN
the/DT
vitality/NN
and/CC
function/NN
of/IN
lymphoid/JJ
cells/NNS
./.
=====
Patients/NNS
with/IN
HIV/NN
infections/NNS
often/RB
show/VBP
elevated/JJ
circulating/JJ
levels/NNS
of/IN
cortisol/NN
,/,
suggesting/VBG
some/DT
misfunction/NN
in/IN
the/DT
regulatory/JJ
systems/NNS
that/WDT
maintain/VBP
the/DT
levels/NNS
of/IN
this/DT
critical/JJ
hormone/NN
./.
=====
At/IN
the/DT
cellular/JJ
level/NN
,/,
it/PRP
is/VBZ
known/VBN
that/IN
both/CC
acute/JJ
HIV/NN
infection/NN
and/CC
glucocorticoids/NNS
can/MD
cause/VB
apoptotic/JJ
cell/NN
death/NN
in/IN
thymic/JJ
lymphocytes/NNS
./.
=====
However/RB
,/,
chronically/RB
HIV-infected/JJ
cells/NNS
appear/VBP
to/TO
be/VB
resistant/JJ
to/TO
glucocorticoid-evoked/JJ
cell/NN
death/NN
./.
=====
Glucocorticoid/NN
receptor-ligand/NN
binding/NN
studies/NNS
on/IN
patients/NNS
'/POS
cells/NNS
have/VBP
shown/VBN
reduced/VBN
affinity/NN
between/IN
the/DT
receptor/NN
binding/NN
sites/NNS
and/CC
test/NN
steroids/NNS
./.
=====
In/FW
vitro/FW
,/,
chronically/RB
HIV-infected/JJ
cells/NNS
of/IN
the/DT
lymphoid/JJ
CEM/NN
line/NN
displayed/VBD
resistance/NN
to/TO
glucocorticoid-induced/JJ
apoptosis/NN
./.
=====
These/DT
cells/NNS
showed/VBD
reduced/VBN
numbers/NNS
of/IN
binding/VBG
sites/NNS
with/IN
little/JJ
alteration/NN
in/IN
apparent/JJ
affinity/NN
between/IN
ligand/NN
and/CC
receptor/NN
./.
=====
Thus/RB
it/PRP
appears/VBZ
that/IN
there/EX
may/MD
often/RB
be/VB
malfunction/NN
of/IN
the/DT
normal/JJ
glucocorticoid/NN
response/NN
in/IN
HIV-infected/JJ
cells/NNS
probably/RB
due/JJ
to/TO
altered/JJ
interactions/NNS
between/IN
the/DT
glucocorticoid/NN
receptor/NN
and/CC
its/PRP$
hormone/NN
./.
=====
Such/JJ
alterations/NNS
may/MD
have/VB
clinical/JJ
consequences/NNS
,/,
including/VBG
the/DT
possibility/NN
of/IN
a/DT
relatively/RB
longer/JJR
life/NN
span/NN
of/IN
infected/JJ
CD4+/JJ
T-lymphocytes/NNS
,/,
as/RB
well/RB
as/IN
systemic/JJ
effects/NNS
of/IN
chronically/RB
elevated/JJ
cortisol/NN
level/NN
./.